MOONLAKE IMMUNOTHERAPEUTICS
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company crating novel therapies, and unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients.
MOONLAKE IMMUNOTHERAPEUTICS
Social Links:
Industry:
Biotechnology
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.moonlaketx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
115 M USD
Stock Details
Investors List
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - MoonLake Immunotherapeutics
Ghost Tree Capital Group
Ghost Tree Capital Group investment in Post-IPO Equity - MoonLake Immunotherapeutics
BVF Partners
BVF Partners investment in Post-IPO Equity - MoonLake Immunotherapeutics
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - MoonLake Immunotherapeutics
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - MoonLake Immunotherapeutics
Tekla Capital Management
Tekla Capital Management investment in Post-IPO Equity - MoonLake Immunotherapeutics
653 Investment Partners
653 Investment Partners investment in Post-IPO Equity - MoonLake Immunotherapeutics
Asymmetry Capital Management
Asymmetry Capital Management investment in Post-IPO Equity - MoonLake Immunotherapeutics
Monashee Investment Management
Monashee Investment Management investment in Post-IPO Equity - MoonLake Immunotherapeutics
Official Site Inspections
http://www.moonlaketx.com Semrush global rank: 5.16 M Semrush visits lastest month: 1.57 K
- Host name: 185-151-30-126.ptr4.stackcp.net
- IP address: 185.151.30.126
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
